0001493152-22-014000.txt : 20220516 0001493152-22-014000.hdr.sgml : 20220516 20220516175330 ACCESSION NUMBER: 0001493152-22-014000 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220516 FILED AS OF DATE: 20220516 DATE AS OF CHANGE: 20220516 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shah Keeren CENTRAL INDEX KEY: 0001898278 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41386 FILM NUMBER: 22931376 MAIL ADDRESS: STREET 1: 55 PARK LANE CITY: LONDON STATE: X0 ZIP: W1K 1NA ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OKYO Pharma Ltd CENTRAL INDEX KEY: 0001849296 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 BUSINESS ADDRESS: STREET 1: 55 PARK LANE CITY: LONDON STATE: X0 ZIP: W1K 1NA BUSINESS PHONE: 44 (0) 207 495 2379 MAIL ADDRESS: STREET 1: 55 PARK LANE CITY: LONDON STATE: X0 ZIP: W1K 1NA 3 1 ownership.xml X0206 3 2022-05-16 0 0001849296 OKYO Pharma Ltd OKYO 0001898278 Shah Keeren C/O OKYO PHARMA LIMITED MARTELLO COURT ADMIRAL PARK ST. PETER PORT Y7 GY1 3HB GUERNSEY 0 1 0 0 Chief Financial Officer Option (right to buy) 0.2025 2028-08-19 Ordinary Shares 300000 D Option (right to buy) 0.0640 2031-08-31 Ordinary Shares 500000 D Option (right to buy) 0.1045 2032-01-31 Ordinary Shares 150000 D 25% will vest each year on August 1, beginning on August 2, 2020. 25% will vest each year on August 1, beginning on August 31, 2021. Vest in equal amounts over three years beginning on January 31, 2022. /s/ Keeren Shah 2022-05-16